A covid-19 vaccine can ensure better outcomes for communities of color. Let’s work to earn their trust.
Dr. Kathryn Stephenson co-wrote this OP-ED for the Washington Post. Read Article
Dr. Kathryn Stephenson co-wrote this OP-ED for the Washington Post. Read Article
Researchers are tracking infected monkeys to determine how long this protection lasts. “Durability studies by their nature take time,” said Dr. Dan Barouch. Read Article
Scientists racing to develop a safe and effective COVID-19 vaccine are turning to what may seem like an odd ally: another family of viruses. Read Article
Dan Barouch, Director of Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center says a vaccine could be available by early-2021, but only if everything goes perfectly during human trials. He also says the duration of immunity of a vaccine is still unknown, pointing out that antibodies in recovered patients declined quickly. See Article
In Boston and in the Netherlands, scientists are racing to build a vaccine against the virus strangling the world. Read Article
“The investment in HIV research has made the response to covid-19 possible,” said Dan H. Barouch. Read Article
“The development of a vaccine for a new pathogen typically takes many years and sometimes decades,” says Dan Barouch. Read Article
The World Health Organization is reporting 17 possible vaccines are in clinical evaluation, with one already in wide-scale human trials.
Dr. Kathryn Stephenson co-wrote this article for STAT. Read Article
Dr. Kathryn Stephenson talks to Science VS Podcast about how soon could we can get a COVID vaccine. Listen Here

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
